O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications (Q48162016)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shin-Hyuk Kang

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Kyung-Jae Park

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Chae-Yong Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Mi Ok Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Chul-Kee Park

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Sung-Hye Park

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Yong-Gu Chung

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

publication date

17 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

101

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

477-486

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

Gliosarcomas: analysis of 11 cases do two subtypes exist?

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Gliosarcoma: a clinical study

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Mechanisms of chemoresistance to alkylating agents in malignant glioma

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

DNA hypermethylation status of multiple genes in soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Genetic profile of gliosarcomas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

O6-methylguanine-DNA methyltranspherase gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

Epigenetic silencing of the MGMT gene in cancer.

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0267-9

21 January 2018

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gliosarcomas in the elderly: analysis of 7 cases and clinico-pathological remarks

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20556478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-010-0267-9

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20556478

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48162016&oldid=2209177817"